Breast Neoplasms
2 competing products in clinical development for Breast Neoplasms.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Abemaciclib + Fulvestrant + Placebo | Eli Lilly | Phase 3 | Active | 77 |
| LY4064809 + Placebo + Ribociclib + Palbociclib + Abemaciclib + Anastrozole + Letrozole + Exemestane + Fulvestrant | Eli Lilly | Phase 3 | Recruiting | 77 |